Ceftazidime is a third generation cephalosporin antibiotic used to treat CNS infections. It can cause side effects like headaches, nausea, and liver toxicity. Nurses should monitor patients for renal and liver dysfunction and obtain cultures before and during therapy to check for sensitivity. They should not mix ceftazidime with aminoglycosides and have vitamin K available in case of bleeding issues.
Ceftazidime is a third generation cephalosporin antibiotic used to treat CNS infections. It can cause side effects like headaches, nausea, and liver toxicity. Nurses should monitor patients for renal and liver dysfunction and obtain cultures before and during therapy to check for sensitivity. They should not mix ceftazidime with aminoglycosides and have vitamin K available in case of bleeding issues.
Ceftazidime is a third generation cephalosporin antibiotic used to treat CNS infections. It can cause side effects like headaches, nausea, and liver toxicity. Nurses should monitor patients for renal and liver dysfunction and obtain cultures before and during therapy to check for sensitivity. They should not mix ceftazidime with aminoglycosides and have vitamin K available in case of bleeding issues.
Indication Generic name: Antibiotic Indication: CNS: headache, Assess for liver and Ceftrazidme Cephalosporin CNS infection dizziness, renal dysfunction (Third Generation) lethargies, Brand name: Contra paresthesis. Culture infection and Tazidim Indication: arrange sensitivity test Contraindicated GI: nausea, before and during Dosage: to patients with vomiting, therapy if expected 300mg allergies to abdominal pain, response is not seen penicillin, anorexia, liver Route: cephalosporin toxicity. Warning: IVTT Do not mix with Hematologic: aminoglycosides Frequency: Bone marrow solutions, administer Q 8 hour depression, these drugs separately ANST (-) decreased WBC, decreased platelets, Powder and decreased Hct. reconstituted solution darken when storage Local: pain, abscess at injection Have vit K available in site, phlebitis, case inflammation at IV hypoprothrombinemia site. occurs